Viral evolution and escape during primary human immunodeficiency virus-1 infection: implications for vaccine design

被引:7
|
作者
Mullins, James I. [2 ,3 ]
Rolland, Morgane [2 ,3 ]
Allen, Todd M. [1 ]
机构
[1] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Partners AIDS Res Ctr, Boston, MA USA
[2] Univ Washington, Sch Med, Dept Microbiol, Seattle, WA 98195 USA
[3] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA
基金
美国国家卫生研究院;
关键词
evolution; HIV; T lymphocyte; viral proteins;
D O I
10.1097/COH.0b013e3282f233d9
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Purpose of review The ability of human immunodeficiency virus to mutate rapidly to evade host immune pressures is a key hurdle limiting the control of human immunodeficiency virus-1 by cellular immune responses. Viral escape from CD8(+) T-cell recognition continues to be studied extensively, and emerging data provide greater appreciation of the affect of these mutations on the virus. These data may help identify key immune responses capable of suppressing viral replication. This goal remains critical, as current vaccines are unlikely to produce protective T-cell immunity. Recent findings Recent studies provide greater understanding of the propensity for transmitted mutations to revert, and of the ability of CD8(+) T-cell escape mutations to impact viral replication capacity and protein structure. These observations reveal important constraints on virus evolution and sequence diversity. Data are also accumulating for the ability of the immune system to mount de-novo CD8(+) T-cell responses against escape variants, revealing an underappreciated complexity of the process of viral escape. Summary Understanding the limits of sequence variation and the impact of immune escape mutations on viral fitness, particularly during acute infection, will be critical to guide the design of contemporary vaccines or therapeutics attempting to force human immunodeficiency viruses to become less fit.
引用
收藏
页码:60 / 66
页数:7
相关论文
共 50 条
  • [1] Rapid evolution of the neutralizing antibody response to human immunodeficiency virus type 1 infection and viral escape
    Richman, D
    RETROVIRUSES OF HUMAN AIDS AND RELATED ANIMAL DISEASES, 2003, : 65 - 66
  • [2] Viral Escape in the Central Nervous System with Multidrug-Resistant Human Immunodeficiency Virus-1
    Beguelin, C.
    Vazquez, M.
    Bertschi, M.
    Yerly, S.
    de Jong, D.
    Gutbrod, K.
    Rauch, A.
    Cusini, A.
    OPEN FORUM INFECTIOUS DISEASES, 2016, 3 (01):
  • [3] THROMBOCYTOPENIA AND HUMAN IMMUNODEFICIENCY VIRUS-1 INFECTION
    WALSH, CM
    KARPATKIN, S
    SEMINARS IN ONCOLOGY, 1990, 17 (03) : 367 - 374
  • [4] Surgery and human immunodeficiency virus-1 infection
    Wastell, C
    Corless, D
    Keeling, N
    AMERICAN JOURNAL OF SURGERY, 1996, 172 (01): : 89 - 92
  • [5] NEUROPATHOLOGY OF THE HUMAN IMMUNODEFICIENCY VIRUS-1 INFECTION
    HENIN, D
    HAUW, JJ
    PRESSE MEDICALE, 1988, 17 (40): : 2129 - 2133
  • [6] Patterns of viral dynamics during primary human immunodeficiency virus type 1 infection
    Kaufmann, GR
    Cunningham, P
    Kelleher, AD
    Zaunders, J
    Carr, A
    Vizzard, J
    Law, M
    Cooper, DA
    JOURNAL OF INFECTIOUS DISEASES, 1998, 178 (06): : 1812 - 1815
  • [7] Finding a Cure for Human Immunodeficiency Virus-1 Infection
    Blankson, Joel N.
    Siliciano, Janet D.
    Siliciano, Robert F.
    INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2014, 28 (04) : 633 - +
  • [8] HUMAN IMMUNODEFICIENCY VIRUS-1 INFECTION IN AN INFERTILE POPULATION
    BRAY, MA
    SOLTES, B
    CLARKE, L
    MINKOFF, H
    SIERRA, MP
    REYES, FI
    FERTILITY AND STERILITY, 1991, 56 (01) : 16 - 19
  • [9] Dynamics of Human Immunodeficiency Virus-1 Genetic Diversification During Acute Infection
    Song, Hongshuo
    Bose, Meera
    Pinyakorn, Suteeraporn
    Sanders-Buell, Eric
    O'Sullivan, Anne Marie
    Silas, Daniel
    Trichavaroj, Rapee
    Nuntapinit, Bessara
    Pham, Phuc T.
    Akapirat, Siriwat
    Kroon, Eugene
    de Souza, Mark
    Gramzinski, Robert
    Michael, Nelson L.
    Robb, Merlin L.
    Vasan, Sandhya
    Tovanabutra, Sodsai
    Ananworanich, Jintanat
    OPEN FORUM INFECTIOUS DISEASES, 2020, 7 (10): : 1 - 4
  • [10] Human immunodeficiency virus-1 vaccine design: where do we go now?
    Wijesundara, Danushka K.
    Jackson, Ronald J.
    Ramshaw, Ian A.
    Ranasinghe, Charani
    IMMUNOLOGY AND CELL BIOLOGY, 2011, 89 (03): : 367 - 374